Australia’s largest provider of cancer care services in Australia, GenesisCare, has today unveiled an advanced cancer care centre at 337 South Terrace, Adelaide.
Representing the first cancer centre of its kind in South Australia, the centre hosts two, 1,800-tonne, steel radiation bunkers above ground, set in a ‘5 Star Green Star Design’ cancer precinct.
Senior Radiation Oncologist at GenesisCare, South Australia, Dr Marcus Dreosti, said he is delighted to be offering access to high-quality care for South Australians living with cancer at the new, integrated cancer care centre.
“I am thrilled to be part of the opening of the new GenesisCare centre in South Australia, & to be offering modern radiation technology to help treat locals living with cancer.”
The GenesisCare cancer care centre offers radiation therapy services & treatment for most cancer types. By early 2024, other healthcare providers in the precinct will be offering imaging, surgery, access to clinical trials for appropriate patients & wellness services, all under the one roof.
GenesisCare General Manager, South Australia, Mr Duy Tran, said “We are excited to be building on our long history of providing high-quality oncology services to South Australian cancer patients, spanning more than 30 years.”
GenesisCare is offering its patients free on-site parking, & access to complimentary transport to & from the centre for eligible regional cancer patients staying at the Cancer Council Greenhill Lodge throughout the course of their treatment.
To learn more, head to: https://www.livhealth.com.au/genesiscare-opens-advanced-cancer-care-centre-in-adelaide/
To hear more about the cancer care centre, listen to Dr Dreosti here: https://www.genesiscaremediakit.com.au/audio-news-grabs
#advanced #cancercare #cancertreatment #cancertherapy #newcancercentre #cancernews
A new, once-a-day oral pill for people living with severe chronic plaque psoriasis is now available for eligible patients via the Pharmaceutical Benefits Scheme (PBS). This represents great news for the estimated 19,000 Australian adults living with this common, inflammatory skin disease.
Providing timely and tailored treatment of psoriasis has become a major public health priority, with recent research highlighting the growing global burden of the disease over the past 30 years.
Specialist dermatologist and founder at Southern Dermatology, Dr Ryan De Cruz, Melbourne, said “severe chronic plaque psoriasis is a chronic, autoimmune, disabling skin condition, that can impact all aspects of your life.
“We know patients who suffer from psoriasis often feel very isolated, they’re unable to wear the clothing they want to wear, they feel itchy, uncomfortable, and it can affect their relationships and their work,” Dr De Cruz said.
Award-winning singer-songwriter, Brian, 57, Melbourne, has been plagued by severe chronic plaque psoriasis for more than 30 years.
“I no longer wanted to be a social butterfly and began to isolate myself.
“I felt heavily rejected, especially by adults when they passed judgment on me. So, I chose to be self-employed, to avoid working with psoriasis in an office setting, or having to be constantly surrounded by people,” said Brian.
After eventually finding a treatment that worked for him, Brian shed substantial weight, which helped to improve both his physical & mental wellbeing.
Brian, therefore welcomes the Federal Government’s PBS listing of a new medicine (tablet) for severe chronic plaque psoriasis today, as “it provides patients with access, & choice”.
To learn more about severe chronic plaque psoriasis, read our blog below and watch our short pieces to camera featuring Dr Ryan De Cruz, and Brian: https://ow.ly/lyXh50PVS5s
#Psoriasis #severe #chronic #plaque #psoriasis #new #PBS #listing #treatment #option
Did you know one in four ophthalmology patients report symptoms of dry eye disease, & one in 10 Australians are affected by this debilitating condition?
Dry eye disease is a chronic eye condition characterised by insufficient or poor-quality tears, resulting in significant discomfort, pain, & inconvenience for those affected. Representing one of the most common reasons for people seeking medical eye care, dry eye disease can substantially compromise a person’s quality of life & work-related productivity.
Anyone can get dry eye disease – but contact lens wearing, prolonged mask use, underlying medical issues, & exposure to certain environmental factors such as air conditioning, can increase an individual’s risk of developing the condition.
Concerningly, dry eye disease is becoming increasingly common, even in those without a history of eye conditions. This may be attributed to heightened levels of digital screen use for work, educational, & social activities, impacting blinking patterns, tear quality, & volume. Australians currently spend a total of 143 days (almost five months) in front of a screen each year.
In good news for the dry eye disease community, CEQUA® (ciclosporin 900 microgram/mL), a ciclosporin eye drop designed to increase tear production where artificial tears have not been sufficient, is now reimbursed on the Pharmaceutical Benefits Scheme (PBS) from Thursday, June 1, 2023, for chronic severe dry eye disease with keratitis.
The listing of this novel eye drop formulation on the PBS is a welcome development, expanding the availability of innovative treatment offerings for those living with dry eye disease.
#CEQUA #eyecare #PBS #reimbursement #newtreatment #dryeyedisease #innovative #ciclosporin #eyedrop
Australian researchers are calling for people aged 40+ living with severe emphysema today (Tuesday, August 2), to volunteer for their study of a new, two-stage procedure for the devastating lung disease.
The study will investigate the safety and effectiveness of a first-in-human procedure for those living with severe emphysema.
The researchers’ call is coinciding with the publication of their article in Medical Journal of Australia’s (MJAs) InSight+, highlighting the need for additional treatment options for those living with severe emphysema.
Without proper management and treatment, emphysema can cause difficulties breathing and talking, a blue tinge to the skin from lack of oxygen, regular chest infections, and may even cause heart failure. These symptoms can also affect a patient’s physical and emotional wellbeing, with up to one in three Australians living with emphysema reporting some level of disability due to the disease.
To register for the COVE Study, head to covestudy.com.au or email [email protected]
#lungdisease #emphysema #researchers #science #clinicaltrials
A new treatment option for our nation’s most common thyroid disorder, hypothyroidism, has been listed on the PBS.
Hypothyroidism is a type of thyroid disease that causes the gland to produce low levels of thyroid hormone. Common symptoms include unexplained weight gain, fatigue, constipation and compromised mental health.
Sydney-based father-to-one and high-tech industry worker, Ross, 41, explains what it’s like to live with hypothyroidism.
Watch his story below.
Goodbye 2021!
Happy New Year's Eve!
Best wishes for a healthy, happy and peaceful New Year!
We can’t wait to share lots more exciting content with you throughout the New Year.
Wishing you all a very Merry Christmas 🎄
We wish everyone a happy & merry holiday & hope everybody gets to spend some quality time relaxing with friends & family.
DId you know, you are about 1cm taller in the morning than in the evening?
Carol Ireland, CEO & Managing Director of Epilepsy Action Australia
Kaitlyn Parratt, Consultant neurologist & epileptologist at Royal Prince Alfred Hospital & Sharp Neurology, Sydney
Amy, 20, Passionate cellist & Sydney Conservatorium of Music student living with epilepsy,
Carol Ireland, CEO & Managing Director, Epilepsy Action Australia
Dr Kaitlyn Parratt - Look for epilepsy
Look for epilepsy this Purple Day